Top

Published in:

Open Access 01-12-2016 | Research article

A 20-year multicentre outcome analysis of salvage mechanical circulatory support for refractory cardiogenic shock after cardiac surgery

Authors: Maziar Khorsandi, Scott Dougherty, Andrew Sinclair, Keith Buchan, Fiona MacLennan, Omar Bouamra, Philip Curry, Vipin Zamvar, Geoffrey Berg, Nawwar Al-Attar

Published in: Journal of Cardiothoracic Surgery | Issue 1/2016

Abstract

Background

Refractory post-cardiotomy cardiogenic shock (PCCS) is a relatively rare phenomenon that can lead to rapid multi-organ dysfunction syndrome and is almost invariably fatal without advanced mechanical circulatory support (AMCS), namely extra-corporeal membrane oxygenation (ECMO) or ventricular assist devices (VAD). In this multicentre observational study we retrospectively analyzed the outcomes of salvage venoarterial ECMO (VA ECMO) and VAD for refractory PCCS in the 3 adult cardiothoracic surgery centres in Scotland over a 20-year period.

Methods

The data was obtained through the Edinburgh, Glasgow and Aberdeen cardiac surgery databases. Our inclusion criteria included any adult patient from April 1995 to April 2015 who had received salvage VA ECMO or VAD for PCCS refractory to intra-aortic balloon pump (IABP) and maximal inotropic support following adult cardiac surgery.

Results

A total of 27 patients met the inclusion criteria. Age range was 34–83 years (median 51 years). There was a large male predominance (n = 23, 85 %). Overall 23 patients (85 %) received VA ECMO of which 14 (61 %) had central ECMO and 9 (39 %) had peripheral ECMO. Four patients (15 %) were treated with short-term VAD (BiVAD = 1, RVAD = 1 and LVAD = 2). The most common procedure-related complication was major haemorrhage (n = 10). Renal failure requiring renal replacement therapy (n = 7), fatal stroke (n = 5), septic shock (n = 2), and a pseudo-aneurysm at the femoral artery cannulation site (n = 1) were also observed. Overall survival to hospital discharge was 40.7 %. All survivors were NYHA class I-II at 12 months’ follow-up.

Conclusion

AMCS for refractory PCCS carries a survival benefit and achieves acceptable functional recovery despite a significant complication rate.

Muehrcke DD, McCarthy PM, Stewart RW, Foster RC, Ogella DA, Borsh JA, et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg. 1996;61(2):684–91.CrossRefPubMed

DeRose Jr JJ, Umana JP, Argenziano M, Catanese KA, Levin HR, Sun BC, et al. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices. Ann Thorac Surg. 1997;64(6):1757–62. discussion 62–3.CrossRefPubMed

Hernandez AF, Grab JD, Gammie JS, O’Brien SM, Hammill BG, Rogers JG, et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation. 2007;116(6):606–12.CrossRefPubMed

Mohite PN, Sabashnikov A, Patil NP, Saez DG, Zych B, Popov AF, et al. Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival. J Artif Organs. 2014;17(3):228–35.CrossRefPubMed

Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139(2):302–11. 11 e1.CrossRefPubMed

Delgado DH, Rao V, Ross HJ, Verma S, Smedira NG. Mechanical circulatory assistance: state of art. Circulation. 2002;106:2046–50.CrossRefPubMed

Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg. 2000;12(3):220–8.CrossRefPubMed

Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34(2):112–20.CrossRefPubMed

Borisenko O, Wylie G, Payne J, Bjessmo S, Smith J, Firmin R, et al. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK. Interact Cardiovasc Thorac Surg. 2014;19(1):41–8.CrossRefPubMed

10.

Khorsandi M, Shaikhrezai K, Prasad S, Pessotto R, Walker W, Berg G, et al. Advanced mechanical circulatory support for post-cardiotomy cardiogenic shock: a 20-year outcome analysis in a non-transplant unit. J Cardiothorac Surg. 2016;11(1). DOI: 10.1186/s13019-016-0430-2.

11.

The official gateway to Scotland 2011 [Available from: http://www.scotland.org/about-scotland/facts-about-scotland/population-of-scotland/. Accessed 11 July 2016.

12.

Akay MH, Gregoric ID, Radovancevic R, Cohn WE, Frazier OH. Timely use of a CentriMag heart assist device improves survival in postcardiotomy cardiogenic shock. J Card Surg. 2011;26(5):548–52.CrossRefPubMed

13.

Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126(22):2648–67.CrossRefPubMed

14.

Mikus E, Tripodi A, Calvi S, Giglio MD, Cavallucci A, Lamarra M. CentriMag venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory postcardiotomy cardiogenic shock. ASAIO J. 2013;59(1):18–23.CrossRefPubMed

15.

Pennington DG, McBride LR, Swartz MT, Kanter KR, Kaiser GC, Barner HB, et al. Use of the Pierce-Donachy ventricular assist device in patients with cardiogenic shock after cardiac operations. Ann Thorac Surg. 1989;47(1):130–5.CrossRefPubMed

16.

Mehta SM, Aufiero TX, Pae Jr WE, Miller CA, Pierce WS. Results of mechanical ventricular assistance for the treatment of post cardiotomy cardiogenic shock. ASAIO J. 1996;42(3):211–8.PubMed

17.

Ko WJ, Lin C, Chen RJ, Wang SS, Lin FY, Chen YS, et al. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg. 2002;73:538–45.CrossRefPubMed

18.

Doll N, Kiaii B, Borger M, Bucerius J, Kramer K, Schmitt D, et al. Five year results of 219 consecutive patients treated with extracorporeal membrane oxygenation after refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004;77:151–7.CrossRefPubMed

19.

Emin A, Rogers CA, Parameshwar J, Macgowan G, Taylor R, Yonan N, et al. Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail. 2013;15(10):1185–93.CrossRefPubMed

20.

Miller LW, Guglin M, Rogers J. Cost of ventricular assist devices: can we afford the progress? Circulation. 2013;127(6):743–8.CrossRefPubMed

21.

Westaby S, Taggart D. Inappropriate restrictions on life saving technology. Heart. 2012;98(15):1117–9.CrossRefPubMedPubMedCentral

22.

Zumbro GL, Kitchens WR, Shearer G, Harville G, Bailey L, Galloway RF. Mechanical assistance for cardiogenic shock following cardiac surgery, myocardial infarction, and cardiac transplantation. Ann Thorac Surg. 1987;44(1):11–3.CrossRefPubMed

23.

Xiao XJ, Luo Z, Ye CX, Fan RX, Yi DH, Ji SY, et al. The short-term pulsatile ventricular assist device for postcardiotomy cardiogenic shock: a clinical trial in China. Artif Organs. 2009;33(4):373–7.CrossRefPubMed

Title: A 20-year multicentre outcome analysis of salvage mechanical circulatory support for refractory cardiogenic shock after cardiac surgery
Authors: Maziar Khorsandi
Scott Dougherty
Andrew Sinclair
Keith Buchan
Fiona MacLennan
Omar Bouamra
Philip Curry
Vipin Zamvar
Geoffrey Berg
Nawwar Al-Attar
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Journal of Cardiothoracic Surgery / Issue 1/2016
Electronic ISSN: 1749-8090
DOI: https://doi.org/10.1186/s13019-016-0545-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A 20-year multicentre outcome analysis of salvage mechanical circulatory support for refractory cardiogenic shock after cardiac surgery

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Hormonal therapy after the operation for catamenial pneumothorax – is it always necessary?

Bedside PDA ligation in premature infants less than 28 weeks and 1000 grams

Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery – a retrospective analysis

Spontaneous fracture and migration of catheter of a totally implantable venous access port via internal jugular vein - a case report

Clinicopathological characteristics of mediastinal follicular dendritic cell sarcoma: report of three cases

The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability